BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27471581)

  • 1. How Grim is Pancreatic Cancer?
    Weledji EP; Enoworock G; Mokake M; Sinju M
    Oncol Rev; 2016 Apr; 10(1):294. PubMed ID: 27471581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The next "sweet" spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection.
    Xu Y; Wang Y; Höti N; Clark DJ; Chen SY; Zhang H
    Mass Spectrom Rev; 2023 Mar; 42(2):822-843. PubMed ID: 34766650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for early pancreatic ductal adenocarcinoma: an urgent call!
    Lee MX; Saif MW
    JOP; 2009 Mar; 10(2):104-8. PubMed ID: 19287101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional endoscopy in the diagnosis and management of pancreatic adenocarcinoma.
    Khokhar AS; Sher AF; Schattner M
    Chin Clin Oncol; 2017 Dec; 6(6):63. PubMed ID: 29307203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resectable carcinoma developing in the remnant pancreas 7 years and 10 months after distal pancreatectomy for invasive ductal carcinoma of the pancreas: report of a case.
    Akabori H; Shiomi H; Naka S; Murakami K; Murata S; Ishida M; Kurumi Y; Tani T
    World J Surg Oncol; 2014 Jul; 12():224. PubMed ID: 25034035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
    Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
    Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of Gustave Roussy immune score in operable pancreatic adenocarcinoma.
    Basoglu T; Babacan NA; Ozturk FE; Arikan R; Demircan NC; Telli TA; Ercelep O; Dane F; Yumuk PF
    Indian J Cancer; 2023; 60(2):179-184. PubMed ID: 36861712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and Perils.
    Schawkat K; Manning MA; Glickman JN; Mortele KJ
    Radiographics; 2020; 40(5):1219-1239. PubMed ID: 32678699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy.
    Ishida J; Toyama H; Matsumoto I; Asari S; Goto T; Terai S; Nanno Y; Yamashita A; Mizumoto T; Ueda Y; Kido M; Ajiki T; Fukumoto T; Ku Y
    Pancreatology; 2016; 16(4):615-20. PubMed ID: 27237099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare pancreatic malignancies.
    Friedman AC; Edmonds PR
    Radiol Clin North Am; 1989 Jan; 27(1):177-90. PubMed ID: 2535686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside.
    Uddin MH; Al-Hallak MN; Philip PA; Mohammad RM; Viola N; Wagner KU; Azmi AS
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods.
    Eskelinen MJ; Haglund UH
    Eur J Surg; 1999 Apr; 165(4):292-306. PubMed ID: 10365829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Silent Asymptomatic Solid Pancreas Tumor in a Nonsmoking Athletic Female: Pancreatic Ductal Adenocarcinoma.
    Lin K; Lin AN; Lin S; Lin T; Liu YX; Reddy M
    Case Rep Gastroenterol; 2017; 11(3):616-624. PubMed ID: 29282381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
    Shahrudin MD
    Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future.
    Pandya GJ; Shelat VG
    World J Gastrointest Oncol; 2015 Feb; 7(2):6-11. PubMed ID: 25685272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatic carcinoma].
    Reissfelder C; Koch M; Büchler MW; Weitz J
    Chirurg; 2007 Nov; 78(11):1059-71; quiz 1072. PubMed ID: 17932632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches.
    Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Papanikolopoulos K; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Karamouzis MV
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of selected chemokines and their specific receptors in pancreatic cancer.
    Łukaszewicz-Zając M; Gryko M; Mroczko B
    Int J Biol Markers; 2018 May; 33(2):141-147. PubMed ID: 29799354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.